SteriPack Group Limited

SteriPack Group Limited specializes in the design, development, and manufacturing of medical and pharmaceutical devices, offering tailored contract manufacturing and packing solutions for various healthcare applications. Founded in 1994 in Ireland, SteriPack Group Limited focuses on the medical and pharmaceutical sectors, providing essential manufacturing and packaging services. The company has successfully completed two significant deals, with the most recent deal occurring on July 1, 2022. The founder's detailed history is not publicly disclosed.

SteriPack specializes in the design, development, and manufacturing of medical and pharmaceutical devices. Its core offerings include comprehensive contract manufacturing, device assembly, and customized packing solutions for complex products related to drug delivery, orthopedics, surgical devices, and diagnostics. SteriPack serves a diverse clientele comprising leading pharmaceutical organizations, healthcare providers, and device manufacturers across North America, Europe, and Asia. The company is known for its user-centric approach, delivering tailored solutions that comply with the specific regulatory and customization requirements of different markets, ensuring healthcare products are optimized from conception to market launch.

SteriPack operates facilities in Poland, the USA, and Malaysia, addressing unique client demands while upholding high service, quality, and compliance standards. In the year 2018, SteriPack generated revenue of USD 37. 30 mn, with an EBITDA of USD 4. 82 mn.

The company primarily earns revenue through contract manufacturing and packing services provided to pharmaceutical and medical device companies, engaging in B2B transactions that allow for end-to-end solutions or specific project stages such as final assembly or kitting of medical products. The pricing structure is tailored to individual project needs, encompassing various service levels and facilitating efficient delivery cycles. SteriPack's reputation for quality and compliance significantly contributes to its revenue streams as clients seek reliable partners in the healthcare market. In July 2022, Inflexion Private Equity Partners agreed to acquire SteriPack Group Limited, with financial terms undisclosed.

This acquisition is aimed at accelerating growth and geographical expansion, while enhancing the service offerings to better support current and future customers. Specific details regarding new products being designed or launched have not been disclosed. The company is likely to focus on expanding into new markets as part of its growth strategy, aligning with the funding received to support these initiatives.